Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia
| Autor: | C. Charasse, Christophe Camus, I. Jouannic-Montier, R. Thomas, Philippe Seguin, J. Bouget, Yves Le Tulzo |
|---|---|
| Rok vydání: | 1996 |
| Předmět: |
Adult
Male medicine.medical_specialty Time Factors medicine.medical_treatment Critical Care and Intensive Care Medicine Statistics Nonparametric Renal Dialysis Anesthesiology Hypovolemia Dialysis Solutions medicine Humans Adverse effect Aged Retrospective Studies Analysis of Variance business.industry Metabolic disorder Retrospective cohort study Middle Aged medicine.disease Surgery Anesthesia Etiology Hypercalcemia Calcium Female Hemodialysis medicine.symptom Emergencies Complication business |
| Zdroj: | Intensive care medicine. 22(2) |
| ISSN: | 0342-4642 |
| Popis: | To assess the efficacy, adverse effects and relevance of calcium-free hemodialysis (CFHD) in the treatment of major hypercalcemia.Retrospective chart review.Medical ICU.All patients admitted over a 9-year period for hypercalcemia requiring urgent treatment and who underwent hemodialysis.CFHD with an acetate dialysate.Thirty-three patients with severe hypercalcemia from various etiologies received CFHD. Marked and rapid decrease of serum total calcium was obtained during all sessions (mean decrease: 1.71 +/- 0.54 mmol/l). Calcium rebound within 24 h after CFHD was observed in all evaluable cases (1 +/- 0.45 mmol/l; mean delay 13.7 +/- 5.8 h). Adverse cardiovascular effects occurred in 17 of 48 sessions (35%) and in 13 of 30 evaluable patients (43%).Adverse effects are frequent during CFHD. After correction of hypovolemia, its use should be restricted to patients with severe clinical symptoms or advanced renal impairment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink